期刊
ANNALS OF TRANSLATIONAL MEDICINE
卷 10, 期 6, 页码 -出版社
AME PUBL CO
DOI: 10.21037/atm-22-619
关键词
Exosomes; cardiovascular diseases (CVDs); miRNA; clinical applications
资金
- National Natural Science Foundation of China [NSFC81860057]
This narrative review focuses on the role of exosomes in cardiovascular diseases (CVDs) and their potential clinical applications. The specific changes in exosome cargos, such as miRNAs and proteins, are found to be associated with the occurrence and development of CVDs, making them meaningful for the diagnosis and prognosis of CVDs. Additionally, exosomes can also be utilized as drug transporters and potential therapeutic methods. Overall, exosomes are expected to serve as meaningful tools in the diagnosis, treatment, and prognosis of CVDs.
Background and Objective: Cardiovascular diseases (CVDs) have been one of the most common threats to human health in recent decades. At present, despite many diagnostic, prognostic and therapeutic methods being applied in the clinic, the prevalence of CVDs continues to rise. Therefore, new discovery is needed and exosomes have received extensive attention. Exosomes are extracellular vesicles that enable communication between cells. They are widely distributed in biofluids, suggesting that they may be useful in CVD diagnosis and prognosis. Furthermore, exosomes are ideal drug transporters with relatively high transport efficiency and the capability to target different kinds of tissues. However, the present research concentrates, for the most part, on mechanistic studies with less attention to clinical applications. Methods: More than 150 relevant scientific articles from databases like PubMed, Web of Science were screened and analysed for this narrative review. Data of clinical trials are collected from clinicaltrials.gov. Key Content and Findings: In this review, we concentrate on different exosomes and CVDs, and we summarize the physiological and pathological roles of CVD-related exosomes. We focused on the role exosomes may have as biomarkers of CVDs, therapeutic opportunities, and possible hurdles to the clinical application of exosomes, aiming to provide a useful reference for its translational use in the CVD field. Conclusions: Specific changes in exosome cargos(mainly miRNAs and proteins) are in accordance with the occurrence and development of CVDs including Acute Myocardial Infarction (AMI), Arrhythmia, Coronary Artery Disease (CAD), Heart Failure (HF) and Cardiomyopathy, therefore meaningful for diagnosis and prognosis of CVDs. For exosome related therapeutic methods, potential ways consist of direct administration of exosomes, targeting on exosome synthesis, processing and release, and working as adjuvants. All in all, exosomes are expected to serve as meaningful tools in the diagnosis, treatment and prognosis of CVDs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据